196 related articles for article (PubMed ID: 26656498)
1. Perfluorooctanoic acid and chronic kidney disease: Longitudinal analysis of a Mid-Ohio Valley community.
Dhingra R; Lally C; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2016 Feb; 145():85-92. PubMed ID: 26656498
[TBL] [Abstract][Full Text] [Related]
2. Perfluorooctanoic acid exposure and natural menopause: A longitudinal study in a community cohort.
Dhingra R; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2016 Apr; 146():323-30. PubMed ID: 26802619
[TBL] [Abstract][Full Text] [Related]
3. Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community.
Darrow LA; Groth AC; Winquist A; Shin HM; Bartell SM; Steenland K
Environ Health Perspect; 2016 Aug; 124(8):1227-33. PubMed ID: 26978841
[TBL] [Abstract][Full Text] [Related]
4. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts.
Winquist A; Steenland K
Epidemiology; 2014 Mar; 25(2):255-64. PubMed ID: 24407430
[TBL] [Abstract][Full Text] [Related]
5. Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant.
Barry V; Winquist A; Steenland K
Environ Health Perspect; 2013; 121(11-12):1313-8. PubMed ID: 24007715
[TBL] [Abstract][Full Text] [Related]
6. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley.
Steenland K; Zhao L; Winquist A; Parks C
Environ Health Perspect; 2013 Aug; 121(8):900-5. PubMed ID: 23735465
[TBL] [Abstract][Full Text] [Related]
7. Polyfluoroalkyl substance exposure in the Mid-Ohio River Valley, 1991-2012.
Herrick RL; Buckholz J; Biro FM; Calafat AM; Ye X; Xie C; Pinney SM
Environ Pollut; 2017 Sep; 228():50-60. PubMed ID: 28505513
[TBL] [Abstract][Full Text] [Related]
8. A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes.
Dhingra R; Winquist A; Darrow LA; Klein M; Steenland K
Environ Health Perspect; 2017 Mar; 125(3):416-421. PubMed ID: 27529882
[TBL] [Abstract][Full Text] [Related]
9. Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers.
Winquist A; Lally C; Shin HM; Steenland K
Environ Health Perspect; 2013 Aug; 121(8):893-9. PubMed ID: 23735518
[TBL] [Abstract][Full Text] [Related]
10. Relation between perfluorooctanoic acid exposure and strokes in a large cohort living near a chemical plant.
Simpson C; Winquist A; Lally C; Steenland K
Environ Res; 2013 Nov; 127():22-8. PubMed ID: 24199934
[TBL] [Abstract][Full Text] [Related]
11. Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure.
Barry V; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2014 Jul; 132():62-9. PubMed ID: 24742729
[TBL] [Abstract][Full Text] [Related]
12. Incidence of type II diabetes in a cohort with substantial exposure to perfluorooctanoic acid.
Karnes C; Winquist A; Steenland K
Environ Res; 2014 Jan; 128():78-83. PubMed ID: 24299613
[TBL] [Abstract][Full Text] [Related]
13. Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.
Worley RR; Yang X; Fisher J
Toxicol Appl Pharmacol; 2017 Sep; 330():9-21. PubMed ID: 28684146
[TBL] [Abstract][Full Text] [Related]
14. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community.
Seals R; Bartell SM; Steenland K
Environ Health Perspect; 2011 Jan; 119(1):119-24. PubMed ID: 20870569
[TBL] [Abstract][Full Text] [Related]
15. Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility.
Hoffman K; Webster TF; Bartell SM; Weisskopf MG; Fletcher T; Vieira VM
Environ Health Perspect; 2011 Jan; 119(1):92-7. PubMed ID: 20920951
[TBL] [Abstract][Full Text] [Related]
16. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community.
Savitz DA; Stein CR; Bartell SM; Elston B; Gong J; Shin HM; Wellenius GA
Epidemiology; 2012 May; 23(3):386-92. PubMed ID: 22370857
[TBL] [Abstract][Full Text] [Related]
17. Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts.
Winquist A; Steenland K
Environ Health Perspect; 2014 Dec; 122(12):1299-305. PubMed ID: 25260175
[TBL] [Abstract][Full Text] [Related]
18. A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA).
Steenland K; Zhao L; Winquist A
Occup Environ Med; 2015 May; 72(5):373-80. PubMed ID: 25601914
[TBL] [Abstract][Full Text] [Related]
19. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project.
Shin HM; Vieira VM; Ryan PB; Steenland K; Bartell SM
Environ Health Perspect; 2011 Dec; 119(12):1760-5. PubMed ID: 21813367
[TBL] [Abstract][Full Text] [Related]
20. PFOA and PFOS serum levels and miscarriage risk.
Darrow LA; Howards PP; Winquist A; Steenland K
Epidemiology; 2014 Jul; 25(4):505-12. PubMed ID: 24807698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
